Shelley Allen

USPTO Granted Patents = 44 (Patent Applications = 8)

CIPO Patents = 10 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 9.2

ph-index = 7

Forward Citations = 234(Granted Patents)

Location History:

Loveland, CO (US) (2008 - 2014)
Niwot, CO (US) (2023)
Boulder, CO (US) (2013 - 2024)

Company Filing History:

Mirati Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

44 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11964989 - KRas G12D inhibitors (2024-04-23),

2. 11802127 - 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors (2023-10-31),

3. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases (2023-10-10),

4. 11691973 - 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors (2023-07-04),

5. 11453683 - KRas G12D inhibitors (2022-09-27),

6. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases (2022-02-15),

7. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases (2021-08-31),

8. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors (2021-06-08),

9. 10889589 - Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain (2021-01-12),

10. 10851080 - Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds (2020-12-01),

11. 10835533 - 1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor (2020-11-17),

12. 10758542 - Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors (2020-09-01),

13. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors (2020-08-04),

14. 10351575 - Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain (2019-07-16),

15. 10323022 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors (2019-06-18),

Title: The Innovative Mind of Shelley Allen

Introduction: Shelley Allen, a pioneering inventor based in Boulder, CO, is known for her groundbreaking contributions to various industries.

Latest Patents: Shelley Allen's latest patents include a cutting-edge technology for sustainable energy production and a revolutionary medical device aimed at improving patient outcomes.

Career Highlights: With a career spanning over two decades, Shelley Allen has established herself as a leading figure in the world of innovation. Her work has been recognized with numerous awards and accolades.

Collaborations: Throughout her career, Shelley Allen has collaborated with top research institutions, universities, and companies to bring her inventions to life. Her ability to work across disciplines has led to the development of truly transformative technologies.

Conclusion: Shelley Allen's passion for innovation and her relentless drive to push the boundaries of what is possible make her a true trailblazer in the field of invention. Her work continues to inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.